These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12950268)

  • 1. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
    Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
    Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of five constitutively activating thyrotrophin receptor mutations.
    Wonerow P; Chey S; Führer D; Holzapfel HP; Paschke R
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):461-8. PubMed ID: 11012571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
    Holzapfel HP; Bergner B; Wonerow P; Paschke R
    Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of the thyroid-stimulating hormone receptor (TSHR) by mutating Ile691 in the cytoplasmic tail segment.
    Liu Z; Fan F; Xiao X; Sun Y
    PLoS One; 2011 Jan; 6(1):e16335. PubMed ID: 21283701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
    Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I; Lima L; Seoane R; Lado-Abeal J
    Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
    Neumann S; Claus M; Paschke R
    Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells.
    Agretti P; De Marco G; Pinchera A; Vitti P; Bernal J; Tonacchera M
    J Endocrinol Invest; 2007 Apr; 30(4):279-84. PubMed ID: 17556863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional significance of the thyrotropin receptor germline polymorphism D727E.
    Sykiotis GP; Neumann S; Georgopoulos NA; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Paschke R; Vagenakis AG; Papavassiliou AG
    Biochem Biophys Res Commun; 2003 Feb; 301(4):1051-6. PubMed ID: 12589819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene.
    Tonacchera M; Agretti P; Pinchera A; Rosellini V; Perri A; Collecchi P; Vitti P; Chiovato L
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1001-8. PubMed ID: 10720030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
    Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.
    Tonacchera M; Van Sande J; Cetani F; Swillens S; Schvartz C; Winiszewski P; Portmann L; Dumont JE; Vassart G; Parma J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):547-54. PubMed ID: 8636266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activities in the thyrotropin receptor: regulation and significance.
    Kleinau G; Biebermann H
    Adv Pharmacol; 2014; 70():81-119. PubMed ID: 24931193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.
    Lado-Abeal J; Castro-Piedras I; Palos-Paz F; Labarta-Aizpún JI; Albero-Gamboa R
    Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient.
    Kosugi S; Hai N; Okamoto H; Sugawa H; Mori T
    Eur J Endocrinol; 2000 Oct; 143(4):471-7. PubMed ID: 11022192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism.
    Claus M; Maier J; Paschke R; Kujat C; Stumvoll M; Führer D
    Thyroid; 2005 Sep; 15(9):1089-94. PubMed ID: 16187920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.